These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 321260)

  • 21. Pituitary function testing in amenorrhea-galactorrhea-hyperprolactinemia.
    Simpson CW; Plunkett ER
    Fertil Steril; 1979 Nov; 32(5):510-7. PubMed ID: 115722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurogenic galactorrhea-amenorrhea.
    Boyd AE; Spare S; Bower B; Reichlin S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1374-7. PubMed ID: 263659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia.
    Badawy SZ; Nusbaum ML; Omar M
    Obstet Gynecol; 1980 Jan; 55(1):1-7. PubMed ID: 6243406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
    Davajan V; Kletzky O; March CM; Roy S; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).
    McIntosh EN
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1192-5. PubMed ID: 945301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hyperprolactinemia-anovulation syndrome.
    Floersheim-Shachar Y; Keller PJ
    Fertil Steril; 1977 Nov; 28(11):1158-63. PubMed ID: 562780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the action of bromocriptine in hyperprolactinemic states. Results of a cooperative trial in 135 patients].
    Fossati P; Strauch G; Tourniaire J
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1687-91. PubMed ID: 986640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amenorrhea, galactorrhea, hyperprolactinemia syndrome and breast carcinoma in a young woman.
    Buytaert P; Viaene P
    Eur J Obstet Gynecol Reprod Biol; 1981 Apr; 11(5):341-6. PubMed ID: 7194824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].
    Hiroi M; Kawakoshi S; Kaneko N
    Horumon To Rinsho; 1983 Jan; 31(1):95-9. PubMed ID: 6682727
    [No Abstract]   [Full Text] [Related]  

  • 39. Ovulatory response to clomiphene citrate during bromocriptine-failed ovulation in amenorrhea-galactorrhea and hyperprolactinemia.
    Turksoy RN; Biller BJ; Farber M; Cetrulo C; Mitchell GW
    Fertil Steril; 1982 Mar; 37(3):441-4. PubMed ID: 6800855
    [No Abstract]   [Full Text] [Related]  

  • 40. Pituitary and ovarian response patterns to stimulation in the postpartum and in galactorrhea-amenorrhea. The role of prolactin.
    del Pozo E; Varga L; Schulz KD; Künzig HJ; Marbach P; del Campo GL; Eppenberger U
    Obstet Gynecol; 1975 Nov; 46(5):539-43. PubMed ID: 1105275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.